Patología dual en Depresión: recomendaciones en el tratamiento
| Autor: | Nestor Szerman, Judit Tirado Muñoz, Joan Ignasi Mestre-Pintó, Adriana Farré, Marta Torrens |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
media_common.quotation_subject Prevalence MEDLINE Medicine (miscellaneous) 03 medical and health sciences 0302 clinical medicine 0502 economics and business mental disorders Medicine Psychiatry Depression (differential diagnoses) media_common Depressió psíquica -- Tractament business.industry Addiction 05 social sciences medicine.disease Comorbidity 3. Good health Psychiatry and Mental health Antidepressant 050211 marketing Substance use business 030217 neurology & neurosurgery Psychopathology |
| Zdroj: | Adicciones |
| ISSN: | 0214-4840 |
| DOI: | 10.20882/adicciones.868 |
| Popis: | Comorbidity between substance use disorders (SUD) and major depression (MD) is the most common dual pathology in the field of addiction to substances and has prevalence rates ranging between 12% and 80%, which complicates the response to treatment and worsens the prognosis of patients. Differentiating between diagnoses of induced depressive episodes and primary depressive episodes concurrent to substance use is especially relevant for therapeutic management. This article presents the state of the art of the currently available pharmacologic treatments of comorbid depression in patients with SUD, taking into account the safety and risk of abuse of antidepressant drugs. Due to the fact that comorbidity of MD and SUD is frequent and presents greater psychopathological and medical severity, as well as worse social functioning, it is crucial to treat MD and SUD simultaneously using the integrated treatment model and not to treat both conditions separately. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|